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Abstract SlOOj3 is a neurite extension factor and has been im- 
plicated in Alzheimer’s disease and Down’s syndrome. It belongs 
to a group of low molecular weight calcium-binding proteins con- 
taining the helix-loop-helix calcium binding motif. The structure 
of only one SlOO protein, calbindin DPk, which has the lowest 
sequence similarity to the other members of the SlOO group has 
been determined. We report the NMR assignments and second- 
ary structure of calcium-free Sloop. The secondary structure is 
similar to that of calbindin DPk, determined using NMR, except 
that there is clear evidence for an additional well ordered 
5-residue a-helix in SlOOp. 
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1. Introduction 
SlOO/? is a member of a group of low molecular weight acidic 
calcium-binding proteins which contain two helix-loop-helix 
calcium binding motifs [l]. One of these calcium binding loops 
is unusual in that it is composed of 14 rather than the normal 
12 amino acids and contains four positively charged amino 
acids. SlOO proteins also contain hydrophobic regions at the 
N-and C-termini which are conserved among the members of 
the group even when their amino acid sequences are not. 
A number of biochemical activities have been reported for 
SlOO/3, including effects on cytoskeletal systems, protein phos- 
phorylation and enzyme activities [ 11. In addition to these intra- 
cellular functions, a disulphide-linked dimer of SlOOa has neu- 
rotrophic activity on selected neuronal populations and mito- 
genie and morphogenic activity on astrocytes [2,3]. The levels 
of SlOO/3 in the brain are elevated in Alzheimer’s disease and 
Down’s syndrome, and the SlOOg is localised primarily in acti- 
vated astrocytes surrounding neuritic plaques [4]. The pattern 
of SlOOp overexpression in Alzheimer’s disease correlates with 
the pattern of regional involvement by neuritic plaques [5], 
suggesting a possible relationship between SlOOg levels and the 
regional distribution of Alzheimer neuropathology. 
Among the members of the SlOO family of proteins, struc- 
tural information exists only for calbindin D,, for which X-ray 
[6] and NMR [7-91 structures are available. Calbindin D,, is the 
protein with the lowest homology to the remainder of the SlOO 
group, having only 27% identity to Sloop. It is also somewhat 
smaller than the other proteins and lacks the C-terminal hydro- 
phobic region. It is therefore not clear that calbindin D,, 
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provides a complete model for the structures of the other SlOO 
proteins. The identification of a growing class of SlOO proteins 
and the likely neurochemical importance of SlOOjl make the 
determination of the structure of SlOOj3 of interest. Two prelim- 
inary crystallisation notes have appeared [lO,l l] but as yet no 
structure has been reported. Here we present NMR assign- 
ments and secondary structural data for this protein in the 
absence of calcium. 
2. Materials and methods 
2.1. Cloning of SIOOB into pET vectors 
DNA was prepared from a culture of the vector pVUSB-1 containing 
the synthetic gene for SlOOg [12]. The SlOO/l gene was then amplified 
using the polymerase chain reaction with the oligonucleotides CCC 
GGG ATG TCT GAA CTC GAG AAA GC and CCC GAT CCT 
TAT TCA TGT TCG AAG AAC TC for forward and reverse strands, 
respectively. These oligonucleotides modified the 5’ and 3’ restriction 
sites to NdeI and BarnHI, respectively. The resulting DNA was cut with 
BamHI and NdeI restriction enzymes and ligated into cut pET1 la and 
pET12a vectors (Novagen) using T4 DNA ligase incubation overnight 
at 16°C. Each of the ligation mixtures was transformed into E. coli 
DHSLY cells. Colonies of these cells were grown in LB ampicillin (100 
&ml) liquid cultures. DNA was isolated, cut with XhoI and PstI and 
run on a 1% agarose electrophoresis gel. The DNA from four clones 
(two in pET1 la and two in pET12a) which had the correct sized inserts 
was isolated. Dyedeoxy terminator PCR sequencing reactions were 
carried out as described in the ABI instructions using both a forward 
primer (corresponding to 20 bp in the T7 promoter region) and a 
reverse primer (corresponding to 18 bp in the T7 terminator region), 
and the sequencing gels were run on an ABI Model 372A DNA se- 
quencing system. This confirmed the correct gene sequence. DNA with 
the correct DNA sequence was transformed into E. co/i BL21 DE3 
pLysS competent cells and then single colonies from these plates plated 
onto LB ampicillin (100 @ml), chloramphenicol (20 &ml) agar 
plates. These colonies were used for protein expression. 
2.2. Expression and purification 
SlOO/l was expressed from the pET12a-S100/3 construct in both 2xYT 
media and 2xM9 media containing 1 g/l of [“N]ammonium chloride as 
the sole nitrogen source. Cultures were grown in 500 ml batches of 
media in 2-litre flasks shaken at 37°C. Media contained 100 pg/rnl 
ampicillin and 50 ,&ml chloramphenicol. When the A,,, reached 1 .O 
for the 2xYT cultures and 0.7 for the 2xM9 cultures expression was 
induced by the addition of 0.5 mM IPTG. After 3 h of further growth 
cells were harvested by centrifugation (8,000 x g, 8 min, 4°C). Cell 
pellets were frozen overnight at -2O”C, thawed and resuspended in 100 
ml of 20 mM Tris-HCl, pH 7.4,5 mM EDTA, 10 mM b-mercaptoetha- 
no1 and disrupted using a French press. After centrifugation as before, 
the supernatant was made 1% in streptomycin sulphate by the dropwise 
addition of a 20% solution and stirred at 4°C for a further 30 min. The 
solution was centrifuged as before, the supernatant made 80% in am- 
monium sulphate (591 g/l), stirred at 4°C for a further 30 min and then 
centrifuged (12,000 x g, 12 min, 4°C). The pH of the supernatant was 
reduced to 4.1 by the addition of 50% sulphuric acid solution. The 
solution was stirred at 4°C for one hour, centrifuged and the pellet 
resuspended in the original isolation buffer and dialysed overnight at 
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Fig. 1. HSQC spectrum of 15N-labelled S 100/I Crosspeaks are labelled with the amino acid residue number. Sidechain amide pairs of crosspeaks are 
shown joined by horizontal lines. The resonance of the sidechain NH of Arg-20 is labelled (20) and is folded about the top of the spectrum. 
4°C against 20 mM Tris-HCl, pH 8.0, 1 mM EDTA, 10 mM B-mercap- 
toethanol, 50 mM sodium chloride. The pH of the dialysed protein was 
adjusted to 8.5 and the solution loaded onto a Hi-Load Q-Sepharose 
anion exchange column which had been equilibrated in 20 mM Tris- 
HCl, pH 8.5, 0.1 mM EDTA, 10 mM/I-mercaptoethanol. The protein 
was eluted with a gradient of (M.6 M sodium chloride in the same 
buffer. The protein eluted at 0.4 M sodium chloride. The protein peak 
was reduced in volume to below 10 ml using a stirred ultrafiltration cell 
(Amicon) with a 3K cutoff membrane and then loaded onto a Hi-Load 
Superdex 75 gel filtration column equilibrated in 10 mM sodium phos- 
phate buffer pH 7.0, 5 mM /3-mercaptoethanol and 0.1 M sodium 
chloride. The SlOO/I eluted after about 165 ml. Fractions containing 
SlOO/I were buffer exchanged by ultrafiltration into water containing 
5 mM [‘H,]succinate, pH 6.5, 0.5 mM [*H,,]dithiothreitol and then 
lyophilised. 
2.3. Analysis 
N-terminal amino acids were determined by automated Edman deg- 
radation on an ABI sequencer. SDS-polyacrylamide gel electrophoresis 
was carried out using the method of Shagger and Von Jagow[l3] in the 
presence or absence of p-mercaptoethanol. 
2.4. NMR spectroscopy 
Samples for NMR contained 6.9 mM SlOO/I (29.3 mg) dissolved in 
400,ul of 20 mM [2H,]succinate (pH 6.3 for 90% H,O/lO% *H,O samples 
and pH* 6.1 for ‘HZ0 samples), 8 mM [‘H,,]dithiothreitol. The volume 
over the sample was purged with nitrogen and the tube sealed. Nmr 
spectra were acquired either on a Bruker AM500 spectrometer or a 
Bruker AMX600 spectrometer. For samples in ‘H,O, spectra were 
acquired with presaturation of the residual H’HO resonance for 1 s with 
about 2 W of rf power. In H,O experiments weaker presaturation was 
combined with ‘jump and return’ [14] selective excitation using a 100 
,US delay between the pulses. The acquisition used a 6024 Hz spectral 
width for spectra recorded in D,O and 7200 Hz for spectra recorded 
in water, and a proton pulse width of about 8 ys (70”). 
Two-dimensional homonuclear spectra were acquired with 2k data 
points in w2 and 512 increments in w,. Sine modulation was used in the 
acquisition of phase sensitive data using the TPPI method [15]. 64128 
scans were acquired per increment so that each spectrum took 12-24 
h to acquire. All homonuclear spectra were acquired at 314k. Heteronu- 
clear ‘H-15N spectra were acquired at a temperature of 311 k with a 1400 
Hz (23 ppm) spectral width for 15N, using CARP 15N decoupling. 
NOESY (100 ms mixing time) and Double Quantum Filtered COSY 
experiments were acquired using standard methods [16,17]. TOCSY 
spectra were acquired using the MLEV-17 [18] mixing sequence and 
mixing times of 30-80 ms. 2D HSQC spectra were acquired with 256 
increments in 0,. 3D HMQC-NOESY (100 ms), 3D HMQC-TOCSY 
(45 ms) and 3D HMQC-NOESY-HMQC (125 ms) experiments were 
carried out using standard pulse sequences [19]; the spectra were ac- 
quired with 512 complex points in the w, (acquisition) dimension, 
respectively 190, 160 and 64 points in the w, dimensions and 72,60 and 
64 points in the w2 (“N) dimensions. 
Two-dimensional data were zero-filled to 1024 data points in the w1 
dimension and multiplied by a Gaussian window function before two- 
dimensional Fourier transformation. Three-dimensional data were 
processed using Felix software (Biosym). The data were multiplied by 
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Fig. 2. Assignment of the a-helix running from Ser-41 to Glu-45. Slices from a 3D HMQC-NOESY (100 ms mixing time) experiment show the way 
in which assignments were established for this region of the protein using inter-residue noes. Lines trace out the pathways used in the assignment 
through the strong NH,-NH; _ , and NH,-PH, _ , noes. The pathway via the weak NH,-aH, _ , noes is also shown where this is visible. The NH,-NH, + , 
noes between F43-L44 and E46-I47 were observed in an HMQC-NOESY-HMQC experiment (not shown). 
a Gaussian function and zero filled to 1024 complex points in the w) 
dimension before Fourier transformation. The w2 and w3 data were 
multiplied by a 70”-shifted sine bell squared function and zero filled to 
512 real points if the dimension was for ‘H or 128 points if for “N. 
Proton chemical shifts are reported relative to 2,2-dimethyl-2-silapen- 
tane-5-sulphonate (DSS) and “N chemical shifts relative to 5 M 
“NH,NO, in 2 M nitric acid. 
3. Results and discussion 
3. I. Expression and purification of SlOOjTi 
In order to obtain high-level expression of SlOO/? for NMR 
spectroscopy, and to facilitate “N-1abelling of the protein, the 
synthetic gene encoding the bovine SlOOa amino acid sequence 
[12] was subcloned into the T7-based expression vectors 
pET12a and pET1 la. The pET12a system was used for expres- 
sion in E. coli BL21 (DE3) pLysS cells. For isotopically normal 
protein, cells were grown in rich 2xYT medium, while for “N- 
labelling minimal 2xM9 medium containing 15NH,Cl was used. 
Yields of pure SlOOB protein were 57 mg/litre culture for 2xYT 
and 29 mg/litre culture for 2xM9 medium. 
3.2. Characterisation of protein 
The expressed protein co-migrated with bovine brain SlOOg 
on SDS gels, confirming previous studies [12]. Electrospray 
mass spectrometry showed that the expressed protein had a 
molecular mass of 10671.77 * 1.1 (calculated 10668.55). The 
sample contained another minor component with a molecular 
weight of 10541 arising from protein molecules lacking the 
N-terminal methionine. N-Terminal sequencing confirmed the 
sequence of the first six residues to be Met, Ser, Glu, Leu, Glu, 
Lys and confirmed that the sample was a mixture of molecules 
with and without the N-terminal methionine. The mass ob- 
tained from electrospray mass spectrometry indicates that the 
protein isolated from the E. coli expression system is fully 
reduced SlOOa and not the disulphide bridged dimer; this was 
confirmed by a non-reducing SDS gel. The linewidths of the 
NMR resonances of SlOO/?, which are unchanged for protein 
concentrations of 1.7-6.9 mM, imply that the protein, although 
fully reduced, is not a monomer in solution. The exact state of 
self association remains to be established. Addition of up to 
2 mM d,O EDTA to a sample caused no linewidth or chemical 
shift changes. Conversely the addition of calcium chloride solu- 
tion caused both linewidth and chemical shift changes and 
allowed us to conclude that our preparation of SlOOp was 
calcium free. 
3.3. Resonance assignment 
The ‘H-“N HSQC spectrum of “N-1abelled SlOOg is shown 
in Fig. 1; it can be seen that there is excellent resolution of the 
backbone amide resonances in this spectrum. This facilitated 
the assignment of the proton and 15N resonances of Sloop, 
using three 3D ‘H-15N experiments and the conventional ap- 
proach of spin-system identification by through-bond connec- 
tivities and sequential assignment by through-space connectivi- 
ties [20]. A 3D HMQC-TOCSY spectrum was used to assign 
the spin systems loosely into groups of possible amino acids on 
PM. Kilby et al. IFEBS Letters 363 (1995) 90-96 93 
??D ??
0 ,w J 
0 
o-b+ n 
o-,+ u 
oe+ w I 
00 ou 
UP 1 o-, on% 0 OU 0 + P 
0 
1 I
‘; d 
0 : as& 
0 
0 
,F- amJ 
1’ II 0 d I 0  3 I ,> * P > ua3 >3 aJ 3 d0 3 
0 : ho4 
the basis of the BH chemical shifts and yH/GH shifts if these 
were present. Due to the short spin-spin relaxation times of the 
protons of this protein, and the fact that many of the NH-aH 
scalar coupling constants are small (see below), many residues 
showed no connectivity beyond the /3H, and the absence of 
further connections could not be used to rule out possible 
spin-system assignments. 
The sequence-specific assignments relied on the identifica- 
tion, in the 3D HMQC-NOESY spectrum, of noes from back- 
bone NH protons to the NH, Ccr or ($9 protons of the preced- 
ing residue. In this way short sequences of spin-systems were 
constructed which could only be fitted into one place in the 
amino acid sequence. The assignment of resonances of residues 
from Leu-40 to Glu-46 is shown in Fig. 2. In this process the 
3D HMQC-NOESY-HMQC spectrum was particularly useful 
since noes between NH protons with very similar chemical 
shifts could be detected provided that the shifts of the directly- 
bonded nitrogens were different. Assignments of 87 out of 91 
backbone amides have been made in this way; these are shown 
in Fig. 1, and the nOe connectivities are summarised in Fig. 3. 
The four residues for which unambiguous assignments have not 
yet been possible are 85-87 and 90, all close to the C-terminus 
of the protein; in addition, the resonances of Met-O, present in 
most but not all of the molecules, have yet to be identified. 
Resonances of the C-terminal Glu-91 were tentatively assigned 
on the basis of four pieces of evidence: (i) its low field 15N shift 
_ the “N resonance of the C-terminal residue is often at low 
field and all the other resonances in this region of the spectrum 
have been assigned; (ii) this resonance has a long 15N spin- 
lattice relaxation time compared to other residues in the pro- 
tein; (iii) the chemical shifts of the other protons in this residue 
were close to those expected for glutamate; and (iv) the “N 
{‘H} nOe for this resonance was negative. The chemical shifts 
of all assigned proton and 15N resonances are summarised in 
Table 1. 
3.4. Secondary structure determination 
The available NMR data which provide information on the 
secondary structure of SlOOa are summarised in Fig. 3; these 
include short- and medium-range noes, NH exchange rates, 
NH-&H coupling constants and the chemical shift index of 
Wishart et al. [21]. The slowly-exchanging NH protons were 
identified by obtaining an HSQC spectrum within one hour of 
dissolving the protein in 2H,0 and again after 24 h. NH protons 
which had not exchanged fell into three regions of the sequence, 
as shown in Fig. 3. An HMQC-J experiment was carried out 
to determine the values of the NH-&H coupling constants. 
For most residues, the coupling constant was too small to lead 
to an observable splitting of the peak; those residues which do 
t 
Fig. 3. NMR data for SlOOg protein. The neighbouring residue nOe 
connections are shown by vertical bars. NOe intensity is indicated by 
the height of the bar. Where overlap prevents observation of noes 
between neighbouring residues * is shown. Medium range noes are 
denoted by horizontal lines where the width of the line indicates nOe 
intensity. Amide proton exchange is shown by ??, @ and o for slow, 
medium and fast exchange, respectively. Large (-7-X Hz) NH-&H 
couplings are shown by J. Chemical shift indices are shown as +, o and 
- for values of +l, 0 and -1. Predicted secondary structure is shown 
with the sequence and secondary structure for calbindin D,, aligned 
under those for SlOOb. 
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Table 1 
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NMR assignments of SlOO/I protein at pH 6.3 and 311 K 
N” NHb CXH BH” Other 
Met-O 
Ser-1 
Glu-2 
Leu-3 
Glu-4 
Lys-5 
Ala-6 
Val-7 
Val-8 
Ala-9 
Leu-10 
Ile- 11 
Asp-12 
Val-13 
Phe-14 
His-15 
Gln-16 
Tyr-17 
Ser- 18 
Gly-19 
Arg-20 
Glu-21 
Gly-22 
Asp-23 
Lys-24 
His-25 
Lys-26 
Leu-27 
Lys-28 
Lys-29 
Ser-30 
Glu-3 1 
Leu-32 
Lys-33 
Glu-34 
Leu-35 
Ile-36 
Asn-37 
Asn-38 
Glu-39 
Leu-40 
Ser-41 
His-42 
Phe-43 
Leu-44 
Glu-45 
Glu-46 
Ile-47 
Lys-48 
Glu-49 
Gln-50 
Glu-5 1 
Val-52 
Val-53 
Asp-54 
Lys-55 
Val-56 
Met-57 
Glu-58 
Thr-59 
Leu-60 
Asp-61 
Ser-62 
Asp-63 
Gly-64 
Asp-65 
Gly-66 
Glu-67 
Cys-68 
Asp-69 
100.1 
100.5 
99.07 
96.88 
103.2 
97.9 
99.4 
102.2 
98.8 
99.9 
100.9 
100.6 
99.6 
102.3 
95.1 
100.6 
102.5 
87.0 
98.0 
95.2 
88.6 
105.2 
105.5 
96.6 
97.1 
99.6 
103.2 
105.9 
93.8 
103.6 
101.9 
99.6 
98.1 
101.7 
100.5 
95.2 
94.6 
94.2 
98.0 
91.8 
102.3 
102.4 
95.0 
97.19 
98.2 
101.4 
106.6 
99.44 
105.4 
96.9 
97.89 
98.9 
99.41 
99.7 
101.9 
96.4 
98.7 
96.7 
101.0 
96.5 
93.9 
101.1 
87.9 
95.8 
89.2 
98.6 
100.0 
102.3 
9.00 
8.95 
8.97 
8.17 
8.45 
7.96 
8.52 
8.57 
7.65 
8.11 
8.59 
8.40 
8.46 
8.39 
8.32 
7.34 
9.56 
8.17 
8.03 
7.15 
7.80 
8.37 
8.59 
8.57 
9.15 
7.66 
8.62 
9.20 
9.06 
9.28 
7.05 
8.34 
8.04 
6.96 
8.09 
8.55 
7.89 
8.36 
9.04 
7.83 
6.84 
9.74 
8.25 
8.18 
1.38 
7.59 
7.68 
8.78 
7.69 
8.49 
9.13 
7.18 
6.86 
8.52 
7.80 
8.07 
8.43 
8.32 
7.99 
7.85 
8.07 
7.82 
7.31 
8.00 
8.13 
8.08 
8.47 
9.37 
8.57 
4.82 
4.04 
4.04 
3.35 
3.89 
4.29 
3.67 
3.50 
4.30 
4.10 
3.39 
4.43 
3.82 
3.50 
3.85 
4.13 
4.00 
3.71, 3.96 
4.17 
4.45 
3.67, 3.85 
4.44 
4.25 
4.91 
5.28 
4.80 
4.87 
3.79 
4.15 
4.33 
3.81 
3.47 
3.98 
3.42 
3.20 
4.19 
4.65 
4.89 
5.06 
3.83 
4.65 
4.51 
4.02 
4.18 
4.55 
3.95 
4.37 
4.74 
3.68 
4.09 
3.64 
3.34 
4.25 
4.13 
3.60 
4.08 
4.03 
3.95 
3.89 
4.47 
4.30 
4.98 
3.84, 3.89 
4.86 
3.83, 4.12 
5.00 
5.15 
5.80 
4.28 
2.07 
1.83 
2.25 
1.87 
1.71 
2.32 
2.23 
1.62 
2.56 
1.75 
2.88 
2.22 
3.15 
2.39, 2.17 
2.61 
1.82 
1.90, 2.12 
2.65 
1.54 
3.65, 3.24 
1.72 
1.37, 1.47 
1.67, 2.33 
2.28 
3.11, 2.85 
2.52, 2.02 
2.39, 2.12 
1.95 
2.28 
1.60 
1.76 
2.65 
2.77, 3.05 
1.69 
2.03, 1.81 
4.02 
3.31, 3.56 
3.37 
1.71 
2.22 
1.97, 2.19 
1.79 
1.68 
2.18, 1.95 
1.94 
2.03 
2.07 
2.11 
2.65 
1.98 
2.31 
2.25 
2.11 
4.48 
1.69 
2.61 
3.99 
2.52 
2.57. 2.80 
2.34, 1.93 
2.68, 3.02 
3.55, 2.74 
~2.45 
yCH, 1.56, 6CH, 0.77, 1.04 
yCH, 1.19, yCH, 0.95 
yCH, 0.99, yCH, 1.25 
1.77 
CH, 0.10, CH, 0.15 
yCH, 1.29, yCH, 1.23 
H6 6.23, HE 7.04, Hc 7.30 
y 1.59 6 3.17, NH, 6.76, 15N 65 
y 1.27, 6 1.50 
y 1.38, 6 0.55 
y 0.81, 6CH, 0.40, 0.62 
yCH, 0.77 
NH, 7.19, 6.33, 15N 88.9 
NH 7.57 7.07 “N 94.4 
2.4; ’ ’ 
y 1.45, 6CH3 0.63, 0.84 
H6 7.14, HE 7.34, H[ 7.41 
yCH, 0.74, 6CH, 1.12, 0.90 
y 1.47 
y 2.37 
yCH, 0.81, 1.01 
yCH, 0.91, 0.91 
y 1.49 
y 0.83, 1.18 
yCH, 1.36 
y 1.67, 6CH, 0.23, 0.43 
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Table 1 (continued) 
N” NHb UH BH’ Other 
Phe-70 
Gin-71 
Glu-72 
Phe-73 
Met-74 
Ala-75 
Phe-76 
Val-77 
Ala-78 
Met-79 
Ile-80 
Thr-8 1 
Thr-82 
Ala-83 
cys-84 
His-85 
Glu-86 
Phe-87 
Phe-88 
Glu-89 
His-90 
Glu-9 1 
99.2 
97.2 
102.0 
100.7 
98.4 
101.9 
98.1 
98.64 
104.2 
97.6 
97.0 
95.48 
89.8 
101.1 
96.3 
93.7 7.46 4.03 3.24, 2.92 
99.2 7.60 4.20 2.15, 1.79 
107.1 8.09 4.02 2.13, 1.85 
9.23 
8.02 
8.39 
8.51 
7.92 
7.58 
8.20 
8.25 
8.58 
7.96 
7.81 
8.21 
7.72 
7.30 
7.59 
3.42 
3.94 
4.34 
3.12 
3.99 
4.28 
3.21 
3.92 
3.86 
3.56 
3.63 
3.31 
4.45 
4.70 
7.04, 7.28 
2.10 
2.31 
3.50, 3.22 H, 6.85, H, 7.05 
1.72 
1.21 
3.04, 2.79 
1.67 yCH, 0.30, 0.59 
1.39 
2.15, 1.86 
2.00 yCH, 0.91 
4.30 yCH, 0.91 
3.92 yCH, 0.68 
1.60 
2.87, 2.75 
a “N chemical shifts are referenced to 5 M “NH,NO, in 2 M HNO, at 0 ppm. 
b ‘H shifts are referenced to 2,2-dimethyl-2-silapentane-5-sulphonate (DSS) at 0 ppm. 
c Where only one PH chemical shift is shown the shifts for both B protons are degenerate. Blanks are left for unassigned atoms. 
have resolved NH-&H couplings are indicated in Fig. 3. Ex- 
amination of the short and medium range noes indicate a 
substantial, approximately 60%, a-helical content of this pro- 
tein as would be expected from its sequence similarity to cal- 
bindin D,,, and this is supported by using the chemical shift 
index method of Wishart et al. [21]. The deduced secondary 
structure of SlOOb is compared to that seen for calcium free 
calbindin D,, in solution [22] in Fig. 3, the two sequences 
having been aligned using the Cameleon program (Oxford Mo- 
lecular Ltd.). With this alignment, Met-O of calbindin corre- 
sponds to residue 4 of Sloop; the first a-helix of SlOO/? includes 
the ‘extra’ N-terminal residues, and extends to approximately 
residue 18. The majority of this helix is very well-defined by 
NH,-NH,. ,, Ha,-NH,., and Hcz~-H/~~+, noes, and slow ex- 
change is observed for the NH protons in the central part of 
the helix. Towards its C-terminus, the helix is less clearly de- 
fined by noes; its exact end is hard to define using the present 
data, but it does appear to stop two or three residues short of 
the corresponding helix in calbindin. The lack of definition of 
the end of this helix is caused in part by resonance overlap but 
mainly by the weak resonances of Ser-18 and Tyr-17 in the 
HSQC spectra which prevented the observation of medium 
range noes to or from these residues. The second helix, from 
Lys-29 to Asn-38, is also well-defined by noes, and corresponds 
closely to the second helix in calbindin. There then appears to 
be a gap of two residues, suggested by the chemical shift index 
and by the observation of large NH-&H coupling constants. 
This is followed by an additional five residues of helix, Ser-41 
to Glu-45, well defined by NH,-NH,+ ,, Hc+NH,+, and Ha,- 
I181+3 noes. This a-helix is not observed in the solution 
secondary structure of calbindin [22] but is in a similar location 
to the ‘irregular helix’ from residues 36 to 41 seen in the crystal 
structure of calbindin [6]. In a recent solution structure of 
calbindin this region is described as an ‘ill-defined ten residue 
loop’, and in calbindin medium range Hai-NH,+ 3 and Hai- 
HA+3 noes are not observed in this region [22,23]. 
Preliminary measurements of r5N (‘H) noes demonstrate that 
residues 4146 have similar large nOe values as the residues in 
the surrounding helices, supporting the conclusion that this 
region is a well-ordered a-helix in SlOO/?. 
The helix from Gln-50 to Asp-62 again corresponds to a helix 
in calbindin, but is perhaps slightly longer. The C-terminal helix 
begins at Glu-71, and is well-defined by noes up to Cys-84. 
Between this point and the C-terminus are several residues 
whose resonances have not yet been assigned, due to a lack of 
clear noes. This may be due to a lack of well-defined structure 
in this region of the protein, and the observation of broad 
HSQC peaks for Thr-82 and Cys-84 would be consistent with 
a looser, only partially helical conformation towards the C- 
terminus of the protein. In addition to the extensive a-helical 
structure, there also appears a four residue P-strand involving 
residues His-25 to Lys-28, and another three residue /?-strand 
involving residues Glu-67 to Asp-69, residues at the ends of the 
two calcium binding loops. These are clearly indicated by the 
chemical shift index method and by the observation of large 
NH-CaH couplings, but only in the latter case is there very 
clear nOe evidence. The only inter-strand nOe yet observed is 
an NH-NH nOe between Leu-27 and Cys-68. 
The results presented here show that SlOO/3 has a generally 
similar secondary structure to calbindin D,,. However, a three 
residue insert compared to calbindin has resulted in the forma- 
tion of a new helix not seen in calbindin. A more detailed 
comparison must await completion of the side-chain resonance 
assignments, which is currently in progress with the aid of 
combined 15N and 13C labelling, and a full tertiary structure 
determination. 
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